HMNC Competitors and Similar CompaniesClear all
HMNC's competitors and similar companies include AgeneBio, NLS Pharmaceutics and Supernus Pharmaceuticals.
 HMNC HMNC is a biotechnology company that establishes personalized medicine in psychiatry and develops medications for depression and anxiety disorders. |  AgeneBio AgeneBio is a pharmaceutical company dedicated to developing therapeutics that prevent neurodegeneration, preserve and restore cognitive brain function. |  NLS Pharmaceutics NLS Pharmaceutics is a biopharmaceutical company engaged in drug discovery for central nervous system disorders. |  Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. | |
Founding Date | Founding Date 2010 | Founding Date 2008 | Founding Date 2019 | Founding Date 2005 |
Type | Type Private | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations München, DE HQ | Locations Baltimore, US HQ Baltimore, US | Locations Stans, CH HQ | Locations Rockville, US HQ |
Employees | Employees 3 | Employees 4 | Employees 6 | Employees 6527% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 10.2 m | Valuation ($) 1.9 b |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $719m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $74.6m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $2.5m (FY, 2024) | Gross profit $644.4m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($2m) (FY, 2024) | Net income ($38.6m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 9.5m | Total funding raised N/A | Total funding raised $ 69.5m |
For sources of this data, please see the company profile
View Company Profiles
AgeneBio
HQ
Baltimore, US
Employees
4
AgeneBio is a pharmaceutical company dedicated to developing therapeutics that prevent neurodegeneration, preserve and restore cognitive brain function.
View companyNLS Pharmaceutics
HQ
Stans, CH
Employees
6
NLS Pharmaceutics is a biopharmaceutical company engaged in drug discovery for central nervous system disorders.
View companySupernus Pharmaceuticals
HQ
Rockville, US
Employees
652↑ 7% increase
Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
View company